Galmed Pharmaceuticals Ltd.
EOCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595353
No open-market purchases or sales by Galmed Pharmaceuticals Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $85.9K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Galmed Pharmaceuticals Ltd. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −9 vs. Q1 2023
- Shares held
- 143.5K
- +6.07K (+4.4%) vs. Q1 2023Converted for a 1-for-15 split
- Total value
- $419.1K
- −$459.2K (−52.3%) vs. Q1 2023
- New holders
- 2
- 4 more added
- Sold out
- 11
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EOCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $85.9K |
| Q1 2026 | 16 | $71.2K |
| Q4 2025 | 17 | $166.4K |
| Q3 2025 | 14 | $102.0K |
| Q2 2025 | 15 | $140.2K |
| Q1 2025 | 13 | $80.4K |
| Q4 2024 | 12 | $142.8K |
| Q3 2024 | 10 | $38.3K |
| Q2 2024 | 13 | $112.9K |
| Q1 2024 | 13 | $57.6K |
| Q4 2023 | 14 | $248.8K |
| Q3 2023 | 17 | $428.2K |
| Q2 2023 | 12 | $419.1K |
| Q1 2023 | 21 | $878.3K |
| Q4 2022 | 22 | $1.21M |
| Q3 2022 | 25 | $803.6K |
| Q2 2022 | 22 | $1.70M |
| Q1 2022 | 23 | $4.47M |
| Q4 2021 | 24 | $7.05M |
| Q3 2021 | 26 | $11.8M |
| Q2 2021 | 25 | $14.6M |
| Q1 2021 | 30 | $19.4M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Galmed Pharmaceuticals Ltd.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 1 | $3 | 0.00% | −286−99.7% | ReducedConverted for a 1-for-15 split |
| ZRC Wealth Management, LLC | 7 | $21 | 0.00% | +0+5.0% | AddedConverted for a 1-for-15 split |
| Allworth Financial LP | 17 | $51 | 0.00% | +0+2.0% | AddedConverted for a 1-for-15 split |
| Bourgeon Capital Management LLC | 34 | $102 | 0.00% | +1+2.0% | AddedConverted for a 1-for-15 split |
| Tower Research Capital LLC (TRC) | 51 | $152 | 0.00% | +51 | New |
| Federation des caisses Desjardins du Quebec | 167 | $499 | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Wells Fargo & Company | 204 | $610 | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| TSFG, LLC | 200 | $1.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Morgan Stanley | 12,498 | $37.4K | 0.00% | −1,118−8.2% | ReducedConverted for a 1-for-15 split |
| Millennium Management LLC | 14,908 | $43.4K | 0.00% | +6,133+69.9% | AddedConverted for a 1-for-15 split |
| Susquehanna International Group, LLP | 25,597 | $74.5K | 0.00% | +25,597 | New |
| BVF Inc | 89,853 | $261.5K | 0.01% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Raymond James & Associates | 0 | $0 | 0.00% | −9,203−100.0% | Sold outConverted for a 1-for-15 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,723−100.0% | Sold outConverted for a 1-for-15 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −2,109−100.0% | Sold outConverted for a 1-for-15 split |
| Western Wealth Management, LLC | 0 | $0 | 0.00% | −1,969−100.0% | Sold outConverted for a 1-for-15 split |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −1,900−100.0% | Sold outConverted for a 1-for-15 split |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −1,860−100.0% | Sold outConverted for a 1-for-15 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −1,812−100.0% | Sold outConverted for a 1-for-15 split |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −937−100.0% | Sold outConverted for a 1-for-15 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −914−100.0% | Sold outConverted for a 1-for-15 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −879−100.0% | Sold outConverted for a 1-for-15 split |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-15 split |